Comerica Securities’s CONMED CNMD Stock Holding History

Comerica Securities’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18	Closed	-$1.6K	–	652
2022 Q4	$1.6K	Buy	+18	New	+$1.49K	﹤0.01%	1274

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Comerica Securities's CNMD Position: Q1 2023 in Review

Comerica Securities sold out of CONMED (CNMD) in Q1 2023, closing a stake of 18 shares — an estimated $1.6K sold.

Comerica Securities first reported a position in CNMD in Q4 2022 and held it in 1 quarter. The position peaked at $1.6K in Q4 2022. 233 funds tracked by Wall St. Rank hold CNMD as of Q1 2023.

Comerica Securities reported no remaining CONMED position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 18 CONMED shares in Q1 2023, an estimated $1.6K.
Comerica Securities first reported a position in CONMED in Q4 2022 and held it in 1 quarter.
Comerica Securities's CONMED position peaked at $1.6K in Q4 2022.
233 funds tracked by Wall St. Rank held CONMED as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.